1. Dunham EW, Haddox MK, Goldberg ND (1974) Alteration of vein cyclic 3?:5?-nucleotide concentrations during changes in contractility. Proc Natl Acad Sci USA 71:815?819
2. Goldberg ND, Haddox MK (1977) Cyclic GMP metabolism and involvement in biological regulation. Ann Rev Biochem 46:823?896
3. Goldberg ND, Haddox MK, Hartle DK, Hadden JW (1973) The biological role of cyclic 3?,5?-guanosine monophosphate. In: Pharmacology and the future of man. Proc 5th Int Congr Pharmacology San Francisco 1972, vol. 5. Karger, Basel, pp 146?169
4. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro LJ (1979) Relaxation of bovine coronary artery and activation of guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res 5:211?224
5. Gruetter CA, Kadowitz PJ, Ignarro LJ (1981) Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. Can J Physiol Pharmacol 59:150?156